Shanghai Tenth People's Hospital

Running trials

• Not yet recruiting

  ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease

  NCT07850063· Phase 3· Boehringer Ingelheim· Source

• Not yet recruiting

  Mazdutide Plus LNG-IUS for Fertility-Sparing Treatment of AEH or Early Endometrial Cancer

  NCT07781150· Phase 2· Tongji Hospital· Source

• Recruiting

  A Clinical Trial of TQF3250 Capsules in Overweight/Obese Trial Participants With Poor Weight Control Through Simple Lifestyle Intervention

  NCT07798284· Phase 1· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Source

• Recruiting

  A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity

  NCT07792954· Phase 3· Pfizer· Source

• Recruiting

  A Study of ATG-022 Compared With Investigator's Choice of Treatment in Claudin 18.2-Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

  NCT07795346· Phase 3· Antengene Biologics Limited· Source

• Recruiting

  A Clinical Trial Evaluating TQF3250 Capsules in Patients With Type 2 Diabetes Mellitus and Overweight/Obesity

  NCT07747857· Phase 1· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Source

• Recruiting

  A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis

  NCT07406035· Phase 2· Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.· Source

• Recruiting

  A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes

  NCT07670416· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management

  NCT07517042· Shanghai Zhongshan Hospital· Source

• Enrolling by invitation

  Amino Acid (15) Peritoneal Dialysis Solution for Nutritional Improvement in Peritoneal Dialysis Patients

  NCT07370441· Phase 4· Shanghai 10th People's Hospital· Source

• Recruiting

  A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer

  NCT07474727· Phase 2· Multitude Therapeutics Inc.· Source

• Recruiting

  LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  NCT07415044· Phase 2· Eli Lilly and Company· Source

• Recruiting

  A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder

  NCT07475806· Phase 2· Astellas Pharma Global Development, Inc.· Source

• Not yet recruiting

  A Clinical Study to Evaluate Injection TQB2102 for the Treatment of Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Progressed After Treatment With Oxaliplatin, Irinotecan and Fluoropyrimidine-Based Drugs

  NCT07483684· Phase 3· Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.· Source

• Recruiting

  A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

  NCT07361302· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification

  NCT07319429· Phase 2/3· Fudan University· Source

• Recruiting

  Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Disease

  NCT07694674· Shanghai 10th People's Hospital· Source

• Recruiting

  Innate Immune Cell Phenotypes and Early Fibrotic Repair in Acute Myocardial Infarction

  NCT07764588· Shanghai 10th People's Hospital· Source

• Not yet recruiting

  Efficacy and Safety of Renal Denervation on Isolated Diastolic Hypertension

  NCT06783296· Shanghai 10th People's Hospital· Source

• Recruiting

  Assessment of the Effects and Safety of Spermidine Supplementation on Blood Lipids and Body Weight in Overweight or Obese Individuals With Hyperlipidemia

  NCT07662330· Shanghai 10th People's Hospital· Source

• Recruiting

  Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer

  NCT07366528· Phase 3· Ruijin Hospital· Source

• Recruiting

  A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  NCT07218380· Phase 3· Eli Lilly and Company· Source

• Recruiting

  Real-world Study of Aflibercept 8 mg in nAMD

  NCT07640997· Peking University People's Hospital· Source

• Recruiting

  Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction

  NCT07110415· Phase 4· SPH Qingdao Growful Pharmacetical Co.,Ltd· Source

• Recruiting

  Efficacy and Safety of QD202 in Participants With Acute Ischemic Stroke Undergoing Thrombolysis Excluding Endovascular Thrombectomy

  NCT07581210· Phase 2· Shanghai QuietD Biotechnology Co., Ltd.· Source

• Recruiting

  A Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer in Adjuvant Setting

  NCT07022483· Phase 3· Daiichi Sankyo· Source

• Recruiting

  Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics

  NCT07261826· Chen QiYi· Source

• Active, not recruiting

  Efficacy and Mechanism of FMT in the Treatment of Inflammatory Bowel Disease: an Open-label Randomized Controlled Study

  NCT07149441· Shanghai 10th People's Hospital· Source

• Not yet recruiting

  DCB for CAD With Type 2 Diabetes

  NCT07009938· Shanghai 10th People's Hospital· Source

• Not yet recruiting

  Intervention Study on Digital Health Management

  NCT06949306· Shanghai 10th People's Hospital· Source

• Not yet recruiting

  Etiological Classification-guided Individual Intervention in Primary Hypertension

  NCT06941935· Shanghai 10th People's Hospital· Source

• Recruiting

  A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

  NCT06952504· Phase 3· Merck Sharp & Dohme LLC· Source

• Recruiting

  A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  NCT06925737· Phase 3· Merck Sharp & Dohme LLC· Source

• Recruiting

  ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis

  NCT06775860· Phase 3· Beijing InnoCare Pharma Tech Co., Ltd.· Source

• Not yet recruiting

  The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).

  NCT06606509· Nanjing First Hospital, Nanjing Medical University· Source

• Not yet recruiting

  Noninvasive Assessment of Pulmonary Fluid Levels by Remote Dielectric Sensing Technology to Improve Cardiac InsUfficieney During Ischemia-Reperfusion and Clinical Outcomes in MyocArdiaL Infarction

  NCT06671067· Shanghai 10th People's Hospital· Source

• Active, not recruiting

  Clinical and Mechanistic Research on Autogenous Arteriovenous Fistula in Hemodialysis Patients

  NCT07058441· Ai Peng· Source

• Active, not recruiting

  Diet Intervention on Obesity Related Complication

  NCT06719466· Zhang Manna· Source

• Active, not recruiting

  EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

  NCT06531824· Phase 3· Boehringer Ingelheim· Source

• Active, not recruiting

  Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)

  NCT06486441· Phase 3· Gilead Sciences· Source

• Not yet recruiting

  Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer

  NCT06475599· Phase 3· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Source

• Active, not recruiting

  Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study)

  NCT06439576· Hoffmann-La Roche· Source

• Recruiting

  A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

  NCT06385925· Phase 1/2· Tyligand Pharmaceuticals (Suzhou) Limited· Source

• Recruiting

  A New Cardiac Rehabilitation Treatment in the Application of Ischemic Heart Disease

  NCT06681506· Shanghai 10th People's Hospital· Source

• Recruiting

  A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients

  NCT06155084· Phase 1/2· Hinova Pharmaceuticals Inc.· Source

• Recruiting

  Multidisciplinary Diagnosis and Treatment of Polycystic Ovary Syndrome

  NCT06047574· Shanghai 10th People's Hospital· Source

• Not yet recruiting

  Assessment and Digital-health Based Intervention on Subclinical Organ Damage and Cardiovascular Risk in Chinese

  NCT05435898· Shanghai 10th People's Hospital· Source

• Enrolling by invitation

  Reinforced Versus Conventional Anastomosis in Laparoscopic Low Rectal Cancer Resection: A Comparative Study

  NCT07346534· Shanghai 10th People's Hospital· Source

• Recruiting

  Study of the Closed-loop Treatment Concept of Atrial Fibrillation in the Atrial Fibrillation Population

  NCT05311137· Shanghai 10th People's Hospital· Source

• Active, not recruiting

  A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)

  NCT05288166· Phase 3· Eli Lilly and Company· Source

Showing 50 of 68.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity8 recruiting
• Endometrial cancer6 recruiting
• Coronary artery disease5 recruiting
• Colorectal cancer4 recruiting
• High blood pressure4 recruiting
• Lung cancer4 recruiting
• Atrial fibrillation3 recruiting
• Gastric and oesophageal cancer3 recruiting
• Heart failure3 recruiting
• Prostate cancer3 recruiting
• Type 2 diabetes3 recruiting
• Bladder cancer2 recruiting
• Crohn's disease2 recruiting
• Liver and biliary tract cancer2 recruiting
• Pancreatic cancer2 recruiting
• Stroke2 recruiting
• Ulcerative colitis2 recruiting
• Atopic dermatitis (eczema)1 recruiting
• Autism1 recruiting
• Chronic kidney disease1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Glioblastoma1 recruiting
• Irritable bowel syndrome1 recruiting
• Macular degeneration1 recruiting
• Melanoma1 recruiting
• Metastatic breast cancer1 recruiting
• Polycystic ovary syndrome1 recruiting
• Psoriasis1 recruiting
• Psoriatic arthritis1 recruiting
• Type 1 diabetes1 recruiting

Closed trials

• Completed

  The Role of L-arginine in Polycystic Ovary Syndrome

  NCT06728644· Shanghai 10th People's Hospital· Source

• Completed

  A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis

  NCT06280716· Phase 3· Eli Lilly and Company· Source

• Completed

  SGLT2 Inhibitors in Treating Patients With PCOS

  NCT05966792· Shanghai 10th People's Hospital· Source

• Completed

  PCOS Patients' Immune Alterations

  NCT06325969· Shanghai 10th People's Hospital· Source

• Completed

  A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis (GPP) Who Need Treatment for Repeated Flares

  NCT06013969· Phase 4· LEO Pharma· Source

• Completed

  Efficacy and Safety of Low-Dose Upadacitinib Combined With Ustekinumab in the Treatment of Refractory Crohn's Disease

  NCT07697547· Shanghai 10th People's Hospital· Source

• Completed

  AP301 Efficacy and Safety in Chinese Dialysis Patients With Hyperphosphatemia

  NCT07030595· Phase 3· Alebund Pharmaceuticals· Source

• Terminated

  Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors (Advanced Cervical Cancer)

  NCT06191900· Grit Biotechnology· Source

• Completed

  A Clinical Evaluation of the RheOx Bronchial Rheoplasty System

  NCT05641207· Energenx Medical LTD.· Source

• Completed

  Clinical Study of Stage IV Psoriasis in Children With Geleli

  NCT05803187· Bio-Thera Solutions· Source

• Completed

  Orlistat Reduces Uric Acid in Overweight/Obese Patients With Hyperuricemia

  NCT05496075· Phase 4· Shanghai 10th People's Hospital· Source

• Completed

  A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)-China Extension Study

  NCT05600309· Phase 3· Merck Sharp & Dohme LLC· Source

• Completed

  A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)

  NCT05064059· Phase 3· Merck Sharp & Dohme LLC· Source

• Completed

  Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

  NCT05003245· Phase 3· Shanghai Henlius Biotech· Source

• Completed

  Using Cryoballoon Ablation as Initial Treatment for Persistent Atrial Fibrillation

  NCT04942834· Ruijin Hospital· Source

• Completed

  Artificial Intelligence-Based Classification and Prognostic Prediction in Small Bowel Crohn's Disease

  NCT07757217· Shanghai 10th People's Hospital· Source

• Completed

  Association Between Age-related Macular Degeneration and Cognitive Impairment Based on Exosome Proteomics

  NCT06883461· Shanghai 10th People's Hospital· Source

• Completed

  Cryo Global Registry

  NCT02752737· Medtronic Cardiac Ablation Solutions· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Thyroid cancer11 works · 0 trials
• Gout5 works · 0 trials